Archive: 2025/12
Primary Biliary Cholangitis Treatment in 2025: What Works, What Changed, and What to Expect
- Dec, 4 2025
In 2025, PBC treatment has shifted dramatically after obeticholic acid was withdrawn. UDCA remains first-line, but seladelpar and elafibranor now offer effective second-line options with better safety and symptom relief.
- Read More
Pre-Medication Strategies: Antiemetics, Antihistamines, and Steroids for Safer Medical Procedures
- Dec, 1 2025
Multiple Sclerosis: Understanding Neurological Deterioration and How Disease-Modifying Therapies Work
- Dec, 1 2025